Eighty-eight patients were randomised and included in the study (BN 52021: 44; placebo: 44) and received at least one dose of the study medication (figure 1). These 88 patients were included in the ...
Experimental and clinical studies suggest that PAF antagonists like BN 52021 appear to be effective in cases of severe Gram-negative septic shock. [6] The outcome of the present multicentre study in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback